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After being notified that 2 high school football team-
mates from New York City were hospitalized with confirmed
or suspected invasive group A streptococcal infections, we
conducted an investigation of possible spread among other
team members. This investigation highlights a need for
guidelines on management of streptococcal and other
infectious disease outbreaks in team sport settings.
G
roup A Streptococcus (S. pyogenes; GAS), a bacteri-
um commonly found on the oropharynx and skin,
causes infections ranging from relatively mild and local-
ized to invasive and potentially life-threatening (1). In
October 2003, the New York City Department of Health
and Mental Hygiene was notified of 2 high school varsity
football teammates hospitalized on the same day, one with
culture-confirmed GAS septic thrombophlebitis and
another with suspected GAS pyoderma.
Case Studies
A 17-year-old male high school student (patient 1) vis-
ited the emergency department of a local hospital in Bronx,
New York, on October 20; he had bilateral groin pain that
had begun 2 days previously, shortly after he played in a
high school football game. He complained of pain with
swallowing but denied fever or chills. His oropharynx was
erythematous but without tonsillar exudate. Abdominal
examination showed suprapubic tenderness and voluntary
guarding. His thighs were tender bilaterally. A rapid
streptococcal antigen throat swab test result was positive.
Computed tomographic (CT) scan of the abdomen sug-
gested acute appendicitis, and CT and duplex ultrasound
confirmed a right external iliac vein thrombus. Exploratory
laparotomy showed a normal appendix and no evidence of
acute pathology. Blood cultures were positive for GAS. He
was treated with antimicrobial agents and anticoagulation
for septic external iliac thrombus.
Another 17-year-old male high school student (patient 2)
from the same football team was hospitalized at the same
hospital on October 20 for a fluctuant right leg mass. Two
weeks previously, he had sought medical care for sore
throat and erythematous skin overlying his right posterior
calf, where he was hit by a helmet during a game. A rapid
streptococcal antigen throat swab test result was positive,
and he was treated with amoxicillin for 10 days. Two days
before admission, he noticed increased swelling and a blis-
ter on his right calf. He was afebrile, and an oropharyngeal
examination was normal. His right lower leg was swollen
posteriorly from behind the knee to the ankle. Blood cul-
ture was negative. The right calf swelling was drained, and
≈1 L of purulent fluid was removed. Results of a rapid
streptococcal antigen test of the aspirated fluid were posi-
tive, but Gram stain and cultures were negative. 
On October 24, 2003, hours before the team’s home-
coming game, the New York City Department of Health
and Mental Hygiene was notified about these hospitalized
teammates. The health department also learned that other
varsity teammates recently had sore throats and skin
lesions. Given the close physical contact and sharing of
equipment and water bottles among players, the health
department launched an epidemiologic investigation that
evening at the high school. Teammates reporting symp-
toms consistent with GAS infection were to be excluded
from play. However, since none of the players reported
having symptoms consistent with acute GAS disease, the
homecoming game was allowed to proceed.
Ascreening questionnaire was designed to identify per-
sons with current or recent throat and skin infections and
risk exposures for GAS. Thirty-three varsity players and 5
coaches were interviewed. Throat cultures from the 33 var-
sity players and 5 coaches were screened for GAS by using
standard methods (2). Isolates from positive culture speci-
mens were characterized by using pulsed-field gel elec-
trophoresis (PFGE) with Sma I and Sfi I enzymes (3). GAS
isolates were tested for susceptibility to chloramphenicol,
clindamycin, erythromycin, penicillin G, tetracycline, and
vancomycin by using standard agar disc diffusion (Kirby-
Bauer, Remel, Lenexa, KS). 
Positive isolates were characterized at the World Health
Organization Collaborating Center for Reference and
Research on Streptococci at the University of Minnesota
Medical School. Isolates were serologically grouped and
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The 33 varsity players and 5 coaches ranged in age
from 15 to 55 years (median age 17 years). None reported
symptoms consistent with acute GAS infection. Among
the 38 throat cultures obtained, 3 (8%) were positive for β-
hemolytic GAS (Table). The only reported exposure to ill
persons was contact with the 2 patients. 
One GAS isolate from an asymptomatic player (speci-
men C) was emm-type 6, and another (specimen B) was
emm-type 75. The isolate from a third asymptomatic play-
er (specimen D) was indistinguishable from that of the
blood culture (specimen A) from patient 1 by PFGE analy-
sis and emm sequencing (type 82). 
During the investigation on October 24, the New York
City Department of Health and Mental Hygiene learned
that the junior varsity team shared equipment and water
bottles with varsity players but did not have the same
close, skin-to-skin contact with the patients as did varsity
teammates. Therefore, the health department screened all
junior varsity players on October 27 but provided treat-
ment only for those whose throat cultures were GAS-pos-
itive. Among 51 junior varsity team members and 3
coaches screened, 4 (7%) had GAS-positive throat cultures
(Table). Two of the 4 reported current or recent symptoms,
including headache and stomachache. The other 2 denied
having symptoms or contact with ill persons. The positive
isolates from junior varsity players were unrelated by
PFGE or emm typing to strains from other varsity or junior
varsity players, including patient 1.
Conclusions
GAS infections are typically spread through contact
with mucus from infected persons or with infected skin
lesions (6). GAS infections in athletic settings could be
transmitted by person-to-person contact, airborne or
droplet spread, or exposure to shared-use items (7). 
In 2002, guidelines for preventing invasive GAS
among household contacts of case-patients were published
(8). These guidelines address the management of house-
hold contacts but not of other types of close, physical con-
tacts (e.g., athletic teams). General guidelines exist
regarding preventing infectious diseases in athletic settings
(7,9). However, no specific recommendations have been
published regarding prevention strategies after invasive
GAS cases have been identified among athletes in contact
sports such as football, a setting where spread of GAS is
possible because of repetitive and forceful skin-to-skin
contact and resultant trauma. 
Although the recommendations advise against routine
screening and prophylaxis for household contacts, prophy-
laxis is recommended in certain situations where host fac-
tors are associated with increased risk for invasive disease
(8). We hypothesized that teammates are at least as likely
to share drinks from common sources and have close, skin-
to-skin contact as are household contacts. Moreover, we
believed that football teammates of our case-patients were
potentially at greater risk for invasive GAS than typical
household contacts because of their greater risk for skin
trauma. Any resultant skin disruption could provide a por-
tal of entry for a more virulent GAS strain from an infect-
ed teammate, potentially leading to invasive GAS disease
even among otherwise healthy persons (10). 
Because of the severity of the patients’illnesses and the
theoretically increased risk for invasive GAS, we screened
and provided antimicrobial prophylaxis to the varsity team
during the initial investigation without awaiting final cul-
ture results. However, the 8% GAS positivity rate was con-
sistent with published estimates of the overall background
colonization rates among schoolchildren (11%–25%) in
nonoutbreak settings (11–13), and lower than the second-
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streptococcal illness (14). Only 1 varsity player carried the
same GAS strain as his septicemic teammate. One of the
unrelated strains isolated from an asymptomatic player
was resistant to erythromycin. This finding emphasizes the
possibility that in some situations macrolide antimicrobial
agents may not be the most effective for prophylaxis.
Given the absence of any additional cases of invasive GAS
or increased GAS carriage rates among the varsity team,
we screened the junior varsity team but treated only play-
ers with positive throat cultures. 
Both hospitalized patients tested positive on rapid strep-
tococcal antigen throat swab tests. Only patient 1 had cul-
ture-confirmed emm-82 invasive GAS; no positive culture
was obtained from patient 2. When patient 2 was assessed
for a fluctuant leg mass, he had already received antimicro-
bial agents for streptococcal pharyngitis. No throat culture
was obtained at initial diagnosis, and subsequent leg fluid
culture was sterile. Although not approved for testing spec-
imens other than throat swabs, rapid antigen testing
(Thermo BioStar Acceava Strep A Test, Thermo Electron
Corporation, Louisville CO) of the leg fluid was positive
for streptococcal antigen, suggesting that GAS was the eti-
ologic agent. The inability of microbiologic techniques to
yield a GAS isolate from patient 2 prevented definitive
linkage of the 2 invasive cases. However, the epidemiolog-
ic link and temporal proximity of infections suggest that
they probably were infected by the same GAS strain.
Furthermore, the high sensitivity and specificity of rapid
antigen detection in diagnosing GAS pyoderma in children
have been demonstrated (15). Of note, emm-82 accounted
for only 3.1% of sterile site isolates in the United States
from 1995 to July 2001 (16). Thus, even relatively uncom-
mon GAS strains can cause serious infections.
How many cases, if any, might have been prevented by
our efforts cannot be determined. However, we received no
additional reports of invasive GAS that were epidemiolog-
ically linked to this football team in the 10 months after the
investigation. 
More information is needed regarding the appropriate
preventive measures for GAS outbreaks among contacts of
invasive GAS patients in athletic settings. Healthcare pro-
fessionals who care for athletes should be reminded of the
potential for outbreaks of infectious diseases. Public health
authorities should share their experiences so additional
information can be gathered on which to establish consen-
sus guidelines for prevention and control of future invasive
GAS clusters or outbreaks occurring among contact sport
participants. 
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